
Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1) confirmed Tuesday it has closed a non-brokered private placement of secured convertible debentures of the company, pursuant to which the company issued and will issue debentures for gross proceeds of $1.31 million.
The proceeds will be used to fund working capital for the company, and for general corporate purposes.